Seres Therapeutics, Inc. — insider transactions

3 transactions on record · MCRB · CIK 1609809

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
3
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
3
Bought, 3m
$0
Sold, 3m
$0
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
—
Director share, 12m
66.7%
of transactions where role is stated
Current run
3 sells
consecutive same-direction transactions
Net 3m flow
$0
purchases minus sales
Total on record
3

Transactions

3 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-07-102026-07-082Ausiello Dennis ADirectorGrant or award6,500$0.00—filing
2026-07-102026-07-082Berenson StephenDirectorGrant or award6,500$0.00—filing
2026-07-102026-07-082Brady KellySee RemarksGrant or award18,750$0.00—filing

Source: U.S. Securities and Exchange Commission, EDGAR

Seres Therapeutics, Inc. insider transactions — 3 filings on record — investment.com